Leppert; Mark F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Leppert; Mark F..The latest application filed is for "apparatus, compositions, and methods for assessment of chronic obstructive pulmonary disease progression among rapid and slow decline conditions".

Company Profile

0.11.14

Leppert; Mark F. - Salt Lake City UT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Apparatus, Compositions, and Methods for Assessment of Chronic Obstructive Pulmonary Disease Progression Among Rapid and Slow Decline Conditions App 20180230542 - Hoidal; John ; et al.	2018-08-16
Apparatus, compositions, and methods for assessment of chronic obstructive pulmonary disease progression among rapid and slow decline conditions Grant 9,885,085 - Hoidal , et al. February 6, 2	2018-02-06
Methods For Identification And Prediction Of Multiple Sclerosis Disease And Therapy Response App 20170306401 - Rose; John W. ; et al.	2017-10-26
Mutant sodium channel Nav1.7 and methods related thereto Grant 9,617,316 - Leppert , et al. April 11, 2	2017-04-11
KCNQ2 and KCNQ3--potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies Grant 9,523,127 - Singh , et al. December 20, 2	2016-12-20
Methods And Compositions For The Diagnosis Of Multiple Sclerosis App 20150259741 - Leppert; Mark F. ; et al.	2015-09-17
MUTANT SODIUM CHANNEL Nav1.7 AND METHODS RELATED THERETO App 20140165219 - Leppert; Mark F. ; et al.	2014-06-12
Mutant Sodium Channel Nav1.7 and Methods Related Thereto App 20120283116 - Leppert; Mark F.	2012-11-08
Mutant Sodium Channel Nav 1.7 And Methods Related Thereto App 20110104665 - Leppert; Mark F. ; et al.	2011-05-05
Autism Associated Genetic Markers App 20100210471 - Leppert; Mark F. ; et al.	2010-08-19
Methods For Identification And Prediction Of Multiple Sclerosis Disease And Therapy Response App 20100167421 - Rose; John W. ; et al.	2010-07-01
Mutant sodium channel Na.sub.v1.7 nucleic acid methods Grant 7,670,771 - Leppert , et al. March 2, 2	2010-03-02
Diagnosis and treatment of herpes simplex virus diseases Grant 7,449,294 - Kriesel , et al. November 11, 2	2008-11-11
Apparatus, Compositions, And Methods For Assessment Of Chronic Obstructive Pulmonary Disease Progression Among Rapid And Slow Decline Conditions App 20080026949 - Hoidal; John ; et al.	2008-01-31
Mutant Sodium Channel Nav1.7 and Methods Related Thereto App 20070275384 - Leppert; Mark F. ; et al.	2007-11-29
KCNQ2 and KCNQ3 - potassium channel genes which are mutated in Benign Familial Neonatal Convulsions (BFNC) and other epilepsies App 20070254297 - Singh; Nanda A. ; et al.	2007-11-01
KCNQ2 and KCNQ3--potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies Grant 7,214,483 - Singh , et al. May 8, 2	2007-05-08
Diagnosis and treatment of herpes simplex virus diseases App 20050250142 - Kriesel, John D. ; et al.	2005-11-10
KCNQ2 and KCNQ3 - potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies App 20030165874 - Singh, Nanda A. ; et al.	2003-09-04
Genetic identification employing DNA probes of variable number tandem repeat loci Grant 5,411,859 - White , et al. May 2, 1	1995-05-02
Genetic identification employing DNA probes of variable number tandem repeat loci Grant 4,963,663 - White , et al. October 16, 1	1990-10-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.